Mar 06, 2024 / 05:30PM GMT
Craig Matthew Hettenbach - Morgan Stanley, Research Division - VP
Great. Well, good morning, everyone. My name is Craig Hettenbach, I cover the healthcare technology for Morgan Stanley. Very pleased to have CFO, Brent Bowman with Veeva with us. So welcome.
Brent R. Bowman - Veeva Systems Inc. - CFO
Thank you. Happy to be very here.
Craig Matthew Hettenbach - Morgan Stanley, Research Division - VP
Oh, very loud. Just for disclosure, I would point you to the morganstanley.com/researchdisclosures.
Questions and Answers:
Craig Matthew Hettenbach - Morgan Stanley, Research Division - VPSo with that, fresh off of earnings last week, I figured we'd start with the current demand environment. And if I take a step back, the life sciences space has seen some headwinds in the last couple of years and you kind of framed the environment as no better than the worst in the last 90 days. So I would love to get a sense, even if it's just between commercial and R&D, some things you